SavedAdd your journal

Journals / Researcher / 2026 / Cilt: 06 Sayı: 01

A Revıew Of The Use Of Bıosensors In Cancer Detectıon: Breast Cancer

Kanser Tespitinde Biyosensörlerin Kullanımına İlişkin Bir İnceleme: Meme Kanseri

Gamze Nur Yüce(BAŞKENT ÜNİVERSİTESİ)0009-0008-9299-7245
Journal
Researcher
Pages
36–41
Publication Date
2026-07-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review discusses some breast cancer biomarkers and their detection by electrochemical biosensors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cancer is defined as the abnormal and uncontrolled growth of cells due to these many changes.
📊
Key Findings & Data:There are more than 200 types of cancer known in the world.
💡
Conclusion & Impact:This review discusses some breast cancer biomarkers and their detection by electrochemical biosensors.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Elektrokimyasal biyosensör · Meme kanseri biyobelirteçleri · Tespit

Abstract

Cancer is defined as the abnormal and uncontrolled growth of cells due to these many changes. There are more than 200 types of cancer known in the world. Accurate diagnostic methods are needed to detect these cancers in the body. The use of biosensors is one of the methods that can serve this purpose. Biosensors can be successful in detecting cancers that are in the early stages, in advanced stages, or that do not respond to treatment. Biosensors are devices designed to detect and analyse a specific biological entity (DNA, protein, RNA, etc.). It can analyse whether the measured analyte is present or not, and if so, in what amount, and convert it into electrical signals. Biosensors require some specific biomarkers to detect cancer cells. This review discusses some breast cancer biomarkers and their detection by electrochemical biosensors.

Özet

Kanser, bu birçok değişime bağlı olarak hücrelerin anormal ve kontrolsüzce büyümesi olarak tanımlanır. Dünyada bilinen 200’den fazla kanser çeşidi bulunmaktadır. Bu kanserleri vücutta tespit edebilmek için doğru tanı yöntemlerine gereksinim duyulmaktadır. Biyosensör kullanımı da bu amaca hizmet edebilecek yöntemlerden biridir. Biyosensörler; Başlangıç evrelerinde tespit edilebilen, ileri evrelerde tespit edilebilen veya tedaviye yanıt vermeyen kanser türlerini tespit etmede başarılı olabilirler. Biyosensörler belirli bir biyolojik varlığı (DNA, protein, RNA vb.) tespit ve analiz etmek için tasarlanmış cihazlardır. Ölçülen analitin bulunup bulunmadığını, bulunuyorsa hangi miktarda bulunduğunu analiz edip elektriksel sinyallere dönüştürebilir. Biyosensörler kanser hücrelerini tespit edebilmek için bazı belirli biyobelirteçlere ihtiyaç duymaktadır. Bu derleme bazı meme kanseri biyobelirteçleri ve elektrokimyasal biyosensörlerin bu belirteçleri tespitini ele almaktadır.

🔖

Cite This Article

Yüce, G. N. (2026). A Revıew Of The Use Of Bıosensors In Cancer Detectıon: Breast Cancer. Researcher, Cilt: 06 Sayı: 01, 36–41. https://ajindex.com/articles/1537215

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (24)

  1. I. E. Tothill, “Biosensors for cancer markers diagnosis”, Semin Cell Dev Biol, c. 20, sy 1, ss. 55-62, Şub. 2009, doi: 10.1016/J.SEMCDB.2009.01.015.
  2. A. M. Kabel, “Tumor markers of breast cancer: New prospectives”, Journal of Oncological Sciences, c. 3, sy 1, ss. 5-11, Nis. 2017, doi: 10.1016/J.JONS.2017.01.001.
  3. M. S. Donepudi, K. Kondapalli, S. J. Amos, ve P. Venkanteshan, “Breast cancer statistics and markers”, J Cancer Res Ther, c. 10, sy 3, ss. 506-511, Tem. 2014, doi: 10.4103/0973-1482.137927.
  4. M. Duffy, “Estrogen Receptors: Role in Breast Cancer”, Crit Rev Clin Lab Sci, c. 43, sy 4, ss. 325-347, Ağu. 2006, doi: 10.1080/10408360600739218.
  5. S. Paruthiyil, H. Parmar, V. Kerekatte, G. R. Cunha, G. L. Firestone, ve D. C. Leitmant, “Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest”, Cancer Res, c. 64, sy 1, ss. 423-428, Oca. 2004, doi: 10.1158/0008-5472.CAN-03-2446.
  6. S. Ménard, S. Fortis, F. Castiglioni, R. Agresti, ve A. Balsari, “HER2 as a Prognostic Factor in Breast Cancer”, Oncology, c. 61, sy Suppl. 2, ss. 67-72, Tem. 2001, doi: 10.1159/000055404.
  7. R. Molina vd., “Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations”, Tumor Biology, c. 26, sy 6, ss. 281-293, Ara. 2005, doi: 10.1159/000089260.
  8. M. J. Duffy vd., “Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)”, Eur J Cancer, c. 75, ss. 284-298, Nis. 2017, doi: 10.1016/J.EJCA.2017.01.017.
  9. G. L. PERKINS, E. D. SLATER, G. K. SANDERS, ve J. G. PRICHARD, “Serum Tumor Markers”, Am Fam Physician, c. 68, sy 6, ss. 1075-1082, Eyl. 2003, Erişim: 01 Aralık 2024. [Çevrimiçi]. Erişim adresi: https://www.aafp.org/pubs/afp/issues/2003/0915/p1075.html
  10. S. Miklikova, L. Trnkova, J. Plava, M. Bohac, M. Kuniakova, ve M. Cihova, “The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer”, Cancers 2021, Vol. 13, Page 575, c. 13, sy 3, s. 575, Şub. 2021, doi: 10.3390/CANCERS13030575.
  11. P. Bertheau vd., “TP53 status and response to chemotherapy in breast cancer”, Pathobiology, c. 75, sy 2, ss. 132-139, Haz. 2008, doi: 10.1159/000123851.
  12. M. Varna, G. Bousquet, L. F. Plassa, P. Bertheau, ve A. Janin, “TP53 Status and Response to Treatment in Breast Cancers”, J Biomed Biotechnol, c. 2011, s. 284584, 2011, doi: 10.1155/2011/284584.
  13. C. Pothipor, S. Bamrungsap, J. Jakmunee, ve K. Ounnunkad, “A gold nanoparticle-dye/poly(3-aminobenzylamine)/two dimensional MoSe2/graphene oxide electrode towards label-free electrochemical biosensor for simultaneous dual-mode detection of cancer antigen 15-3 and microRNA-21”, Colloids Surf B Biointerfaces, c. 210, s. 112260, Şub. 2022, doi: 10.1016/J.COLSURFB.2021.112260.
  14. A. McGuire, J. A. L. Brown, ve M. J. Kerin, “Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring”, Cancer and Metastasis Reviews 2015 34:1, c. 34, sy 1, ss. 145-155, Şub. 2015, doi: 10.1007/S10555-015-9551-7.
  15. B. Bohunicky ve S. A. Mousa, “Biosensors: the new wave in cancer diagnosis”, Nanotechnol Sci Appl, c. 4, sy 1, s. 1, 2010, doi: 10.2147/NSA.S13465.
  16. V. S. P. K. S. A. Jayanthi, A. B. Das, ve U. Saxena, “Recent advances in biosensor development for the detection of cancer biomarkers”, Biosens Bioelectron, c. 91, ss. 15-23, May. 2017, doi: 10.1016/J.BIOS.2016.12.014.
  17. A. Mohammadpour-Haratbar, Y. Zare, ve K. Y. Rhee, “Electrochemical biosensors based on polymer nanocomposites for detecting breast cancer: Recent progress and future prospects”, Adv Colloid Interface Sci, c. 309, s. 102795, Kas. 2022, doi: 10.1016/J.CIS.2022.102795.
  18. A. Mohammadpour-Haratbar, S. B. A. Boraei, Y. Zare, K. Y. Rhee, ve S. J. Park, “Graphene-Based Electrochemical Biosensors for Breast Cancer Detection”, Biosensors 2023, Vol. 13, Page 80, c. 13, sy 1, s. 80, Oca. 2023, doi: 10.3390/BIOS13010080.
  19. P. Kiani vd., “Electrochemical biosensors for early detection of breast cancer”, Clinica Chimica Acta, c. 564, s. 119923, Oca. 2025, doi: 10.1016/J.CCA.2024.119923.
  20. P. G. C. Selwyna, P. R. Loganathan, ve K. H. Begam, “Development of electrochemical biosensor for breast cancer detection using gold nanoparticle doped CA 15-3 antibody and antigen interaction”, International Conference on Signal Processing, Image Processing and Pattern Recognition 2013, ICSIPR 2013, c. 1, ss. 75-81, 2013, doi: 10.1109/ICSIPR.2013.6497963.
  21. H. Li, J. He, S. Li, ve A. P. F. Turner, “Electrochemical immunosensor with N-doped graphene-modified electrode for label-free detection of the breast cancer biomarker CA 15-3”, Biosens Bioelectron, c. 43, sy 1, ss. 25-29, May. 2013, doi: 10.1016/J.BIOS.2012.11.037.
  22. J. Zhao vd., “Amplified electrochemical detection of surface biomarker in breast cancer stem cell using self-assembled supramolecular nanocomposites”, Electrochim Acta, c. 283, ss. 1072-1078, Eyl. 2018, doi: 10.1016/J.ELECTACTA.2018.07.002.
  23. W. Wang, X. Fan, S. Xu, J. J. Davis, ve X. Luo, “Low fouling label-free DNA sensor based on polyethylene glycols decorated with gold nanoparticles for the detection of breast cancer biomarkers”, Biosens Bioelectron, c. 71, ss. 51-56, Eyl. 2015, doi: 10.1016/J.BIOS.2015.04.018.
  24. M. Sadeghi, S. Kashanian, S. M. Naghib, F. Haghiralsadat, ve D. Tofighi, “An Efficient Electrochemical Biosensor Based on Pencil Graphite Electrode Mediated by 2D Functionalized Graphene Oxide to Detect HER2 Breast Cancer Biomarker”, Int J Electrochem Sci, c. 17, sy 4, s. 220459, Nis. 2022, doi: 10.20964/2022.04.62.